Current Clinical Data and Products in AMI Cardiogenic Shock
This series of courses reviews the clinical evidence pathway to a Class I recommendation in AMI Cardiogenic Shock. Data reviewed includes NCSI and SWG updates, best practices from the Inova experience, best practices from IQ and CVAD registries, and an update on Impella 5.5 outcomes. The science of ECpella is also reviewed, demonstrating how the Impella technology optimizes unloading during the use of ECMO.
Course Outline 1:48:45
Clinical Evidence Pathway to Class I Recommendation in AMI Cardiogenic Shock
6:29
Best Practices learned from IQ and cVAD
24:15
Updates from NCSI
20:21
Best Practices Learned from the INOVA Experience
13:48
Recover IV & Shock Working Group Updates
14:03
Impella 5.5® Outcomes
17:11
Science of “ECPella™” – Impella Technology Optimizations for Unloading During ECMO
12:38